Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Anthropocene Institute is a multi-disciplinary research and advocacy organization that focuses on accelerating technological solutions to global challenges, including climate change and human health. In the life sciences sector, the Institute is recognized for its work in drug repurposing, notably spearheading research into the use of famotidine for the treatment of COVID-19. Beyond infectious diseases, the organization actively supports initiatives in longevity and the biology of aging, seeking to identify interventions that extend healthy human lifespan. It operates as an incubator and strategic partner, bridging the gap between academic discovery and clinical application. The Institute's health-related efforts are integrated into a broader portfolio that includes significant work in advanced nuclear energy and environmental conservation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anthropocene Institute.